Skip to main content
MRKR logo

MRKR · Marker Therapeutics, Inc. · Metrics

Track MRKR — free
$1.09 -0.23 (-17.42%) At close · Nov 20 Q1 2021 earnings call transcript
Market Cap
$18.17M
Shares
16.67M
Volume · Nov 20 1.97M Avg daily vol (3M) 703.97K

MRKR metrics

64 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.09
Market cap
$18.17M

Price action

23 metrics
Price change (1W)
+25.3%
Price change (30D)
+13.5%
Price change (3M)
-21.6%
Price change (6M)
-22.1%
Price change (YTD)
-26.8%
Price change (1Y)
+10.1%
Trailing year
Price change (5Y)
—
52-week high
$2.19
52-week low
$0.83
Change from 52-week high
-50.2%
Change from 52-week low
+31.5%
Annualized volatility
101.4%
Annualized volatility (3M)
143.4%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.6
RSI (14D)
54.5
Price vs SMA 50
+5.4%
Price vs SMA 200
-16.3%
Avg volume (3M)
703,970
Relative volume
2.8
Average dollar volume
$893,693

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
16.67M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.6×
reciprocal yield 21.7%
P / book
1.7
reciprocal yield 57.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-47.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.1×
reciprocal yield 32.1%
EV / revenue historical average (5Y)
3.1×
reciprocal yield 32.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2021-11-10

Profitability

9 metrics
Gross margin
—
Operating margin
-363.5%
Trailing 12 months
Net margin
-343.0%
Gross profit (TTM)
—
Operating profit (TTM)
−$9.36M
Net income (TTM)
−$8.55M
Trailing 12 months
Diluted EPS (TTM)
$-0.33
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.63

Growth

11 metrics
Revenue growth YoY
+115.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.95M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+15.3%
Year over year · more shares
Revenue CAGR (3Y)
+0.3%
Revenue CAGR (5Y)
+48.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-81.4%
Return on assets
-68.4%
Debt / equity
—
Current ratio
6.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
6.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$9.04M
Total assets
$12.50M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$9.52M
Capital expenditures (TTM)
—
R&D (TTM)
$8.63M
SG&A (TTM)
—
Stock compensation (TTM)
$667,175
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
36
13F filer change QoQ
+1
Institutional ownership
23.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
14.3%
Private-fund adviser ownership
13.9%
Active holders' share change QoQ
-1.7%
Holder tenure
18.9
Price vs estimated holder cost
-65.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.3%

Short interest

3 metrics
Short interest
1.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
70 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1094038 CUSIP 57055L206 13F (30d) 51 filings 34 filers Visit website Investor relations